Description
Lapatinib Generic in India
Lapatinib is an anti-cancer medication used primarily for HER2-positive breast cancer treatment.
Indian companies such as Natco and Cipla manufacture it, making treatment more budget-friendly. It is a tablet that is consumed orally and blocks cancer growth. The medicine is often used when other treatments stop working. Always consult a doctor before use.
Lapatinib Manufacturers and Brands in India
Lapatinib is manufactured by several Indian pharmaceutical companies, ensuring a steady supply of this life-saving drug. Some of the most popular Lapatinib brands in India for 250 mg medication include:
- Herduo by Natco Pharma
- Hertab by Hetero
- Combinib by Cipla
The availability of multiple brands ensures that patients have options to choose from based on cost and availability.
Lapatinib Cost in India
The cost of Lapatinib in India is significantly lower compared to international markets. This is primarily due to the presence of multiple generic manufacturers, which helps reduce the overall price.
Contact us to learn more about the pricing and how to obtain Lapatinib from trusted sources.
Lapatinib for Breast Cancer
Lapatinib is commonly prescribed for HER2-positive breast cancer, especially for patients who do not respond well to trastuzumab (Herceptin). It works by blocking HER2 and EGFR (epidermal growth factor receptor) pathways, slowing cancer growth.
Side Effects of Lapatinib
Some common side effects of Lapatinib are:
- Diarrhea
- Nausea and vomiting
- Fatigue
- Skin rashes
- Loss of appetite
Lapatinib vs Trastuzumab
- Mechanism: Lapatinib is a tyrosine kinase inhibitor (TKI), while trastuzumab is a monoclonal antibody.
- Usage: Lapatinib is taken orally, whereas trastuzumab is given intravenously.
- Effectiveness: In some cases, Lapatinib is used when trastuzumab stops working.
Lapatinib vs Erlotinib
- Mechanism: Lapatinib inhibits HER2 and EGFR, while Erlotinib targets EGFR only.
- Usage: Lapatinib treats HER2-positive breast cancer, often with capecitabine. Erlotinib is not standard for breast cancer.
- Effectiveness: Lapatinib is proven for HER2-positive cases, whereas Erlotinib lacks significant efficacy in breast cancer treatment.
FAQs
How to take Lapatinib?
Lapatinib is taken orally, usually once daily, with or without food. Follow your doctor’s instructions carefully.
How does Lapatinib work?
Lapatinib blocks the signals that HER2-positive cancer cells need to grow and divide.
What type of drug is Lapatinib?
Lapatinib is a targeted therapy drug, specifically a tyrosine kinase inhibitor.
How much does Lapatinib cost?
The cost of Lapatinib in India ranges from ₹5,000 to ₹14,000, depending on the dosage and brand
References –
https://www.natcopharma.co.in/wp-content/uploads/2024/04/Herduo-Lapatinib-DH-PIL_Natco-V4.pdf
https://en.wikipedia.org/wiki/Lapatinib
NOTE:
This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does not include all information about the possible uses, directions, side effects, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This is prescription medicine and if you want to buy this medication legally from Delightaid Health, we require a valid prescription from you. Please consult with your doctor before taking this medicine. Only your doctor can decide which medicine is good for you. Please read the disclaimer and prescription-related full details at the bottom of this website.
Genuine Customer Review
Reviews
There are no reviews yet.